AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

MariMed Inc.

$0.07 -$0.01 (-16.67%)
OTC · 15 Sep 2026 16:46 UTC
Previous Close
$0.08
Day Range
$0.07$0.07
Year Range
$0.06$0.18
Market Cap
29.94M
AVG Volume
492.86K
Trailing/Forward PE
-1.99/-
PEG ratio
0.08
Dividend Yield
-
Next Earnings Date
2026-11-04
Primary Exchange
Other OTCUS
Revenue (USD)
050M100M150M200M2016201720182019202020212022202320242025
MRMD Revenue (USD) by year
PeriodRevenue (USD)
2025159.98M
2024157.96M
2023148.6M
2022134.01M
2021121.46M
202050.9M
201945.6M
201811.85M
20176.07M
20163.56M
Net Income (USD)
-100M-75M-50M-25M025M2016201720182019202020212022202320242025
MRMD Net Income (USD) by year
PeriodNet Income (USD)
2025-14.3M
2024-12.15M
2023-16.05M
202213.47M
20217.22M
20202.14M
2019-81.18M
2018-13.6M
2017-1.19M
2016-201.01K
Operating Income (USD)
-60M-40M-20M020M40M2016201720182019202020212022202320242025
MRMD Operating Income (USD) by year
PeriodOperating Income (USD)
2025-2.07M
20243.26M
202312.23M
202222.83M
202126.86M
202014.53M
2019-41.61M
2018-5.36M
20171.21M
2016614.73K
EBITDA (USD)
-75M-50M-25M025M50M2016201720182019202020212022202320242025
MRMD EBITDA (USD) by year
PeriodEBITDA (USD)
20259.44M
202414.19M
202313.12M
202226.04M
202128.96M
202016.3M
2019-70.67M
2018-10.35M
201790.37K
2016856.68K
Cash Flows (USD)
-40M-20M020M2016201720182019202020212022202320242025
MRMD Cash Flows (USD) by year
PeriodCash Flows (USD)
20256.53M
2024-1.12M
2023-12.85M
2022-5.43M
202117.29M
2020-1.56M
2019-34.12M
2018-11.83M
2017-19.74M
2016-3.56M
EPS (USD)
-0.4-0.3-0.2-0.1-00.12016201720182019202020212022202320242025
MRMD EPS (USD) by year
PeriodEPS (USD)
2025-0.04
2024-0.03
2023-0.04
20220.04
20210.02
20200
2019-0.35
2018-0.07
2017-0
2016-0
Expenses (USD)
020M40M60M80MR&DSG&ACapex2016201720182019202020212022202320242025
MRMD Expenses (USD) by year
PeriodExpenses (USD)
202531.29M
202446.43M
202371.48M
202251.62M
202156.1M
202020.75M
201923.08M
201827.62M
201724.54M
20165.05M
Cash & Debt (USD)
025M50M75M100MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
MRMD Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20258.88M
20247.28M
202314.73M
20229.86M
202129.93M
20204.36M
20192.19M
20184.1M
20171.29M
2016569.36K
Debt ratios
-20020406020182019202020212022202320242025
MRMD Debt ratios by year
PeriodDebt ratios
20251.45
20240.99
20231
202240.49
20210.16
2020-0.59
2019-0.51
2018-1.11
Margins
0%20%40%60%80%2016201720182019202020212022202320242025
MRMD Margins by year
PeriodMargins
202536.28%
202435.39%
202340.04%
202247.73%
202154.55%
202061.55%
201941.01%
201865.9%
201759.03%
201662.07%
Return on Capital
-1500%-1000%-500%0%500%2016201720182019202020212022202320242025
MRMD Return on Capital by year
PeriodReturn on Capital
2025-28.59%
2024-20.3%
2023-22.96%
202223.5%
202119.9%
202026.47%
2019-1282.9%
2018-22.03%
2017-10.85%
201636.45%
Shares Outstanding
0100M200M300M400M2016201720182019202020212022202320242025
MRMD Shares Outstanding by year
PeriodShares Outstanding
2025395.3M
2024379.15M
2023376.01M
2022339.44M
2021324.27M
2020281.54M
2019230.83M
2018208.65M
2017171.15M
201664.21M
Book Value Per Share (USD)
-0.100.10.20.32016201720182019202020212022202320242025
MRMD Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20250.13
20240.16
20230.19
20220.17
20210.11
20200.03
20190.03
20180.3
20170.06
2016-0.01
Total Assets (USD)
0100M200M300M2016201720182019202020212022202320242025
MRMD Total Assets (USD) by year
PeriodTotal Assets (USD)
2025202.56M
2024206.99M
2023196.12M
2022152.2M
2021123.2M
202076.45M
201961.57M
201882.96M
201732.2M
20168.56M
Employee Count
02505007501K2016201720182019202020212022202320242025
MRMD Employee Count by year
PeriodEmployee Count
2025808
2024715
2023643
2022592
2021260
2020181
201981
201828
201712
20164
PE Ratio
050100150200med 27.15Feb 22May 22Sep 22Dec 22Apr 23Jul 23Nov 23
MRMD PE Ratio by year
PeriodPE Ratio
Nov 2318.73
Oct 2319.81
Oct 2324.64
Oct 2323.65
Oct 2324.17
Sep 2326.97
Sep 2328.48
Sep 2331.58
Sep 2329.66
Sep 2326.25
Aug 2318.1
Aug 2317.52
Aug 2317.95
Aug 2322.03
Jul 2315.11
Jul 2315.72
Jul 2316.04
Jul 2316.31
Jun 2316.31
Jun 2315.72
Jun 2315.52
Jun 2316.44
Jun 2316.31
May 2316.31
May 2318.3
May 2319.5
May 2311.85
Apr 239.64
Apr 239.74
Apr 239.58
Apr 239.58
Mar 239.89
Mar 239.58
Mar 2310.36
Mar 2311.29
Mar 2310.96
Feb 2379.31
Feb 2381.52
Feb 2372.98
Feb 2375.05
Jan 2371.08
Jan 2368.15
Jan 2372.41
Jan 2369.01
Dec 2261.45
Dec 2265.56
Dec 2267.29
Dec 2280.23
Dec 2289.72
Nov 2291.44
Nov 2289.72
Nov 2292.3
Nov 22129.57
Oct 22129.14
Oct 22134.62
Oct 22138.36
Oct 22162.05
Sep 22108.02
Sep 22107.2
Sep 22132.13
Sep 22143.35
Sep 22147.09
Aug 22154.32
Aug 22152.07
Aug 22163.79
Aug 2236.87
Jul 2238.19
Jul 2240.03
Jul 2236.87
Jul 2230.55
Jul 2225.29
Jun 2224.23
Jun 2227.34
Jun 2230.45
Jun 2232.13
May 2232.5
May 2232.66
May 2232.66
May 2226.48
Apr 2228.73
Apr 2231.87
Apr 2232.54
Apr 2232.99
Apr 2233.21
Mar 2233.48
Mar 2231.19
Mar 2213.68
Mar 2213.29
Feb 2214.15
Feb 2214.39
Feb 2216.24
Feb 2215.87
Jan 2213.1
Jan 2214.21
Jan 2215.28
Jan 2216.24
Dec 2115.96
Dec 2113.93
Dec 2113.47
Dec 2114.12
Free Cash Flow Yield
-10%0%10%20%30%40%med 3.95%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
MRMD Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 2626.83%
Sep 2626.22%
Sep 2625.82%
Aug 2625.04%
Aug 2624.08%
Aug 2630.38%
Aug 2622.57%
Jul 2624.27%
Jul 2623.25%
Jul 2623.24%
Jul 2622.49%
Jul 2622.58%
Jun 2621.38%
Jun 2621.84%
Jun 2622.16%
Jun 2621.07%
May 2619.6%
May 2620.39%
May 2622.96%
May 2619.43%
May 2618.46%
Apr 2620.9%
Apr 2624.29%
Apr 2623.63%
Apr 2624.83%
Mar 2621.79%
Mar 2621.59%
Mar 2619.92%
Mar 264.89%
Feb 264.84%
Feb 265.12%
Feb 265.13%
Feb 264.69%
Jan 264.73%
Jan 264.52%
Jan 264.39%
Jan 264.51%
Jan 264.56%
Dec 254.19%
Dec 253.71%
Dec 253.83%
Dec 254.98%
Nov 254.58%
Nov 254.85%
Nov 254.87%
Nov 254.03%
Oct 254.65%
Oct 253.59%
Oct 253.71%
Oct 253.44%
Oct 253.66%
Sep 253.95%
Sep 253.95%
Sep 254.13%
Sep 253.65%
Aug 253.62%
Aug 255.04%
Aug 255.15%
Aug 255.81%
Aug 250.87%
Jul 250.73%
Jul 250.91%
Jul 250.82%
Jul 250.99%
Jun 251.22%
Jun 251.22%
Jun 251.18%
Jun 251.19%
May 251.01%
May 251.15%
May 251.07%
May 250.9%
May 25-2.73%
Apr 25-2.74%
Apr 25-2.97%
Apr 25-3.8%
Apr 25-3.42%
Mar 25-3.06%
Mar 25-3.04%
Mar 25-2.88%
Mar 25-2.71%
Feb 25-4.05%
Feb 25-3.41%
Feb 25-3.07%
Feb 25-3.51%
Jan 25-4.09%
Jan 25-3.8%
Jan 25-4%
Jan 25-4.14%
Jan 25-3.57%
Dec 24-3.85%
Dec 24-3.89%
Dec 24-3.52%
Dec 24-3.18%
Nov 24-3.14%
Nov 24-3.08%
Nov 24-2.85%
Nov 24-2.81%
Nov 24-4.57%
Oct 24-4.47%
Price to Sales
0.10.20.30.40.5med 0.23Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
MRMD Price to Sales by year
PeriodPrice to Sales
Sep 260.19
Sep 260.19
Sep 260.2
Aug 260.2
Aug 260.21
Aug 260.17
Aug 260.17
Jul 260.16
Jul 260.16
Jul 260.16
Jul 260.17
Jul 260.17
Jun 260.18
Jun 260.17
Jun 260.17
Jun 260.18
May 260.19
May 260.18
May 260.16
May 260.21
May 260.22
Apr 260.2
Apr 260.17
Apr 260.17
Apr 260.16
Mar 260.19
Mar 260.19
Mar 260.2
Mar 260.21
Feb 260.21
Feb 260.2
Feb 260.2
Feb 260.22
Jan 260.22
Jan 260.23
Jan 260.23
Jan 260.23
Jan 260.22
Dec 250.24
Dec 250.28
Dec 250.27
Dec 250.21
Nov 250.22
Nov 250.21
Nov 250.21
Nov 250.25
Oct 250.3
Oct 250.39
Oct 250.38
Oct 250.41
Oct 250.38
Sep 250.36
Sep 250.36
Sep 250.34
Sep 250.39
Aug 250.39
Aug 250.28
Aug 250.27
Aug 250.24
Aug 250.24
Jul 250.28
Jul 250.23
Jul 250.25
Jul 250.21
Jun 250.17
Jun 250.17
Jun 250.18
Jun 250.17
May 250.2
May 250.18
May 250.19
May 250.23
May 250.26
Apr 250.26
Apr 250.24
Apr 250.19
Apr 250.21
Mar 250.23
Mar 250.23
Mar 250.25
Mar 250.26
Feb 250.27
Feb 250.33
Feb 250.36
Feb 250.32
Jan 250.27
Jan 250.29
Jan 250.28
Jan 250.27
Jan 250.31
Dec 240.29
Dec 240.28
Dec 240.32
Dec 240.35
Nov 240.35
Nov 240.36
Nov 240.39
Nov 240.39
Nov 240.39
Oct 240.4
EV/EBITDA
510152025med 11.1Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
MRMD EV/EBITDA by year
PeriodEV/EBITDA
Sep 2611.2
Sep 2611.28
Sep 2611.32
Aug 2611.42
Aug 2611.55
Aug 2610.85
Aug 2610.23
Jul 2610.06
Jul 2610.16
Jul 2610.16
Jul 2610.24
Jul 2610.23
Jun 2610.37
Jun 2610.32
Jun 2610.28
Jun 2610.41
May 2610.61
May 2610.5
May 2610.19
May 2613.22
May 2613.4
Apr 2612.97
Apr 2612.51
Apr 2612.59
Apr 2612.44
Mar 2612.83
Mar 2612.86
Mar 2613.13
Mar 2610.92
Feb 2610.94
Feb 2610.8
Feb 2610.79
Feb 2611.03
Jan 2611.01
Jan 2611.14
Jan 2611.22
Jan 2611.14
Jan 2611.11
Dec 2511.36
Dec 2511.77
Dec 2511.66
Dec 2510.87
Nov 2511.1
Nov 2510.94
Nov 2510.93
Nov 2511.49
Oct 2510.79
Oct 2511.97
Oct 2511.8
Oct 2512.2
Oct 2511.87
Sep 2511.49
Sep 2511.49
Sep 2511.29
Sep 2511.89
Aug 2511.93
Aug 2510.48
Aug 2510.4
Aug 259.99
Aug 2510
Jul 2510.6
Jul 259.88
Jul 2510.21
Jul 259.63
Jun 259.11
Jun 259.11
Jun 259.19
Jun 259.17
May 259.56
May 259.24
May 259.43
May 259.92
May 258.62
Apr 258.61
Apr 258.39
Apr 257.81
Apr 258.04
Mar 258.31
Mar 258.33
Mar 258.47
Mar 258.64
Feb 2517.57
Feb 2518.73
Feb 2519.54
Feb 2518.53
Jan 2517.51
Jan 2517.98
Jan 2517.64
Jan 2517.44
Jan 2518.39
Dec 2417.89
Dec 2417.81
Dec 2418.5
Dec 2419.26
Nov 2419.36
Nov 2419.52
Nov 2420.16
Nov 2420.28
Nov 2418.1
Oct 2418.26
Price/Operating Cashflow
010203040med 5.5Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
MRMD Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 263.32
Sep 263.4
Sep 263.45
Aug 263.56
Aug 263.7
Aug 262.93
Aug 263.66
Jul 263.41
Jul 263.55
Jul 263.56
Jul 263.68
Jul 263.66
Jun 263.87
Jun 263.78
Jun 263.73
Jun 263.92
May 264.22
May 264.06
May 263.6
May 264.37
May 264.6
Apr 264.06
Apr 263.49
Apr 263.59
Apr 263.42
Mar 263.89
Mar 263.93
Mar 264.26
Mar 268.56
Feb 268.64
Feb 268.17
Feb 268.15
Feb 268.92
Jan 268.85
Jan 269.26
Jan 269.54
Jan 269.28
Jan 269.17
Dec 259.98
Dec 2511.28
Dec 2510.91
Dec 258.4
Nov 259.13
Nov 258.62
Nov 258.59
Nov 2510.39
Oct 2524.02
Oct 2531.09
Oct 2530.07
Oct 2532.49
Oct 2530.52
Sep 2528.26
Sep 2528.26
Sep 2527.05
Sep 2530.62
Aug 2530.86
Aug 2522.13
Aug 2521.66
Aug 2519.2
Aug 257.67
Jul 259.12
Jul 257.36
Jul 258.17
Jul 256.76
Jun 255.49
Jun 255.5
Jun 255.7
Jun 255.65
May 256.6
May 255.82
May 256.27
May 257.47
May 256.06
Apr 256.04
Apr 255.58
Apr 254.36
Apr 254.84
Mar 255.41
Mar 255.45
Mar 255.76
Mar 256.11
Feb 254.15
Feb 254.93
Feb 255.47
Feb 254.79
Jan 254.1
Jan 254.42
Jan 254.2
Jan 254.06
Jan 254.7
Dec 244.36
Dec 244.31
Dec 244.77
Dec 245.28
Nov 245.34
Nov 245.45
Nov 245.88
Nov 245.97
Nov 243.49
Oct 243.57
Price to Book
0.40.60.811.2med 0.65Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
MRMD Price to Book by year
PeriodPrice to Book
Sep 260.71
Sep 260.73
Sep 260.74
Aug 260.76
Aug 260.79
Aug 260.63
Aug 260.58
Jul 260.54
Jul 260.56
Jul 260.56
Jul 260.58
Jul 260.58
Jun 260.61
Jun 260.6
Jun 260.59
Jun 260.62
May 260.67
May 260.64
May 260.57
May 260.67
May 260.71
Apr 260.62
Apr 260.54
Apr 260.55
Apr 260.53
Mar 260.6
Mar 260.6
Mar 260.66
Mar 260.61
Feb 260.61
Feb 260.58
Feb 260.58
Feb 260.63
Jan 260.63
Jan 260.66
Jan 260.68
Jan 260.66
Jan 260.65
Dec 250.71
Dec 250.8
Dec 250.77
Dec 250.6
Nov 250.65
Nov 250.61
Nov 250.61
Nov 250.74
Oct 250.81
Oct 251.05
Oct 251.02
Oct 251.1
Oct 251.03
Sep 250.96
Sep 250.96
Sep 250.92
Sep 251.04
Aug 251.05
Aug 250.75
Aug 250.73
Aug 250.65
Aug 250.63
Jul 250.75
Jul 250.61
Jul 250.67
Jul 250.56
Jun 250.45
Jun 250.45
Jun 250.47
Jun 250.46
May 250.54
May 250.48
May 250.52
May 250.61
May 250.69
Apr 250.68
Apr 250.63
Apr 250.49
Apr 250.55
Mar 250.61
Mar 250.62
Mar 250.65
Mar 250.69
Feb 250.64
Feb 250.76
Feb 250.84
Feb 250.74
Jan 250.63
Jan 250.68
Jan 250.65
Jan 250.62
Jan 250.72
Dec 240.67
Dec 240.66
Dec 240.73
Dec 240.81
Nov 240.82
Nov 240.84
Nov 240.9
Nov 240.92
Nov 240.89
Oct 240.91
MariMed Inc.
MRMD
Stockpicker

Video analysis: MRMD

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: MRMD

MariMed Inc. (MRMD) Q2 2026 Earnings Call Transcript

seekingalpha.com · 13 Aug 2026

MariMed Inc. (MRMD) Q2 2026 Earnings Call Transcript

MariMed Inc. (MRMD) Q2 2026 Earnings Call Transcript

MariMed Reports Second Quarter 2026 Earnings

globenewswire.com · 12 Aug 2026

MariMed Reports Second Quarter 2026 Earnings

NORWOOD, Mass., Aug. 12, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the second quarter ended June 30, 2026.

MariMed Embraces Pumpkin Season By Unveiling New Products That Bring Seasonal Autumn Flavors to Cannabis Consumers

globenewswire.com · 6 Aug 2026

MariMed Embraces Pumpkin Season By Unveiling New Products That Bring Seasonal Autumn Flavors to Cannabis Consumers

NORWOOD, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQB:MRMD) is gearing up for a cozy fall with a line of limited-edition product offerings for the season.

MariMed Announces Second Quarter 2026 Earnings Date

globenewswire.com · 15 Jul 2026

MariMed Announces Second Quarter 2026 Earnings Date

NORWOOD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its second quarter 2026 financial results on August 12, 2026 after the markets close.

MariMed Announces Second Quarter 2026 Earnings Date

globenewswire.com · 15 Jul 2026

MariMed Announces Second Quarter 2026 Earnings Date

NORWOOD, Mass. , July 15, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or the "Company") (CSE: MRMD) (OTCQB: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its second quarter 2026 financial results on August 12, 2026 after the markets close.

MariMed's Betty's Eddies™ Expands Core Lineup with New Multi-Vitamin Inspired Betty's Bite-A-Mins

globenewswire.com · 14 Jul 2026

MariMed's Betty's Eddies™ Expands Core Lineup with New Multi-Vitamin Inspired Betty's Bite-A-Mins

NORWOOD, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Betty's Eddies ™, the all-natural cannabis fruit chews handcrafted for specific health and wellness effects, is expanding its core lineup with the introduction of Betty's Bite-A-Mins, a daily wellness chew that combines full-spectrum cannabis, CBD, and essential vitamins in one delicious bite.

MariMed's Nature's Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign

globenewswire.com · 7 Jul 2026

MariMed's Nature's Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign

NORWOOD, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- MariMed's (“MariMed”) (CSE: MRMD) (OTCQB: MRMD) award-winning flower, vape and concentrate brand, Nature's Heritage™ , today announced the launch of ‘The Nose Knows,' an immersive, science-backed consumer education campaign designed to help consumers better understand which cannabis products and strains align best to their preferences.

MariMed Submits DEA Registration Applications For State-Licensed Medical Cannabis Businesses

globenewswire.com · 25 Jun 2026

MariMed Submits DEA Registration Applications For State-Licensed Medical Cannabis Businesses

NORWOOD, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator, today announced the Company has submitted applications with the U.S. Drug Enforcement Agency (“DEA”) to register certain state-licensed medical cannabis operations.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.